The cost-effectiveness of zemplar in the Netherlands

被引：0
|
作者：
Nuijten, MJ
Siegert, C
机构：
[1] Ars Accessus Medica Erasmus Univ, Rotterdam, Netherlands
[2] St Lucas Andreas Hosp, Amsterdam, Netherlands
来源：
VALUE IN HEALTH | 2006年 / 9卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)64336-7
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A7 / A8
页数：2
相关论文
共 50 条
  • [21] COST-EFFECTIVENESS OF TARGETED SCREENING FOR HEPATITIS C IN THE NETHERLANDS
    Helsper, C. W.
    Borkent-Raven, B. A.
    de Wit, N. J.
    van Essen, G. A.
    Bonten, M.
    Janssen, M. P.
    Hoepelman, I
    De Wit, G. A.
    VALUE IN HEALTH, 2009, 12 (07) : A429 - A429
  • [22] Cost-effectiveness of additional blood screening tests in the Netherlands
    Borkent-Raven, Barbara A.
    Janssen, Mart P.
    van der Poel, Cees L.
    Bonsel, Gouke J.
    van Hout, Ben A.
    TRANSFUSION, 2012, 52 (03) : 478 - 488
  • [23] COST-EFFECTIVENESS OF UNIVERSAL VACCINATION AGAINST VARICELLA IN THE NETHERLANDS
    de Boer, P. T.
    Postma, M. J.
    VALUE IN HEALTH, 2013, 16 (07) : A357 - A357
  • [24] Cost-effectiveness of prucalopride in the treatment of chronic constipation in the Netherlands
    Nuijten, Mark J. C.
    Dubois, Dominique J.
    Joseph, Alain
    Annemans, Lieven
    FRONTIERS IN PHARMACOLOGY, 2015, 6
  • [25] Cost-effectiveness of mass vaccination with a rotavirus vaccine in the Netherlands
    Al, M. J.
    Goossens, L.
    Hovels, A. M.
    Michielsen, C. P.
    Standaert, B. A.
    VALUE IN HEALTH, 2006, 9 (06) : A304 - A304
  • [26] Cost-effectiveness of obinutuzumab for chronic lymphocytic leukaemia in The Netherlands
    Blommestein, Hedwig M.
    de Groot, Saskia
    Aarts, Mieke J.
    Vemer, Pepijn
    de Vries, Robin
    van Abeelen, Annet F. M.
    Posthuma, E. F. M. Ward
    Uyl-de Groota, Carin A.
    LEUKEMIA RESEARCH, 2016, 50 : 37 - 45
  • [27] Cost-effectiveness of pathogen inactivation for platelet transfusions in the Netherlands
    Postma, MJ
    van Hulst, M
    De Wolf, JTM
    Botteman, M
    Staginnus, U
    TRANSFUSION MEDICINE, 2005, 15 (05) : 379 - 387
  • [28] COST-EFFECTIVENESS OF RITUXIMAB IN THE TREATMENT OF RA PATIENTS IN THE NETHERLANDS
    Diamantopoulos, A.
    Kievit, W.
    De Vries, R.
    Pompen, M.
    VALUE IN HEALTH, 2011, 14 (07) : A311 - A311
  • [29] The cost-effectiveness of hearing-aid fitting in the Netherlands
    Joore, MA
    van der Stel, H
    Peters, HJM
    Boas, GM
    Anteunis, JC
    ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2003, 129 (03) : 297 - 304
  • [30] Cost-effectiveness model for a specific mixture of prebiotics in The Netherlands
    Lenoir-Wijnkoop, I.
    van Aalderen, W. M. C.
    Boehm, G.
    Klaassen, D.
    Sprikkelman, A. B.
    Nuijten, M. J. C.
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2012, 13 (01): : 101 - 110
12345